In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

A gut check for heart failure patients

Risk Factors and Prevention
Heart Failure

Athens, Greece – 26 May 2019:  Heart failure patients who consume more dietary fibre tend to have healthier gut bacteria, which is associated with reduced risk of death or need of a heart transplant. The fibre study was presented today at Heart Failure 2019, a scientific congress of the European Society of Cardiology (ESC).1

“Our gut microbiota is composed of trillions of microorganisms that have the potential to affect our health,” said study author Dr Cristiane Mayerhofer, of Oslo University Hospital, Norway. “Previous research has reported reduced biodiversity of microbes in the gut of patients with heart failure patients. Today we show for the first time that this is related to low fibre intake.”

The study also linked meat intake to higher levels of trimethylamine-N-oxide (TMAO) in patients with heart failure. Prior research has shown that increased TMAO levels are associated with a greater risk of cardiovascular events, and that gut microbes play a role in its formation.

“We show an important pathway that connects diet, microbial activity, and cardiovascular disease,” said Dr Mayerhofer. ”It would be prudent for patients with heart failure to limit their meat intake to two to three times a week.”

To conduct the study, the investigators recruited 84 well-treated patients with chronic heart failure and 266 healthy people. The composition of gut microbes was assessed by sequencing the bacterial 16S rRNA gene in stool samples and compared between the two groups.

Heart failure patients had lower biodiversity of intestinal microbes than healthy controls, with differences in the two main phyla of bacteria present in the human gut. Patients with heart failure had a lower ratio of Firmicutes/Bacteroidetes (F/B) compared to controls, and this difference was even more pronounced when the cause of heart failure was non-ischaemic

Dietary and outcome analyses were performed in heart failure patients. Patients who had a heart transplant or died had lower biodiversity and a lower F/B ratio than controls. Regarding diet, bacterial diversity and Firmicutes levels were positively associated with fibre intake.

“Our findings suggest that the altered microbiota composition found in patients with chronic heart failure might be connected to low fibre intake,” said Dr Mayerhofer. “If these findings are confirmed in future studies, my advice will be to choose foods high in fibre such as cereals, fruits and vegetables to stimulate a healthy gut flora.”

“We are still just in the beginning of mapping and understanding the microbiota, how it works, and its potential for the clinical setting,” noted Dr Mayerhofer.

She is currently involved with GutHeart, the first randomised controlled trial on the effect of a probiotic and an antibiotic on the composition of gut bacteria, heart function, and inflammation in patients with heart failure.2 “The trial will show the potential clinical effects of modulating our gut bugs in the setting of heart failure,” she said.

ENDS

Notes to editor

Authors: ESC Press Office
Tel: +33 (0)4 8987 2499
Mobile: +33 (0)7 8531 2036
Email: press@escardio.org

Follow us on Twitter @ESCardioNews 

The hashtag for Heart Failure 2019 and the World Congress on Acute Heart Failure is #heartfailure2019.

 

Funding: Norwegian Health Association.

Disclosures: None.

 

References 

1The abstract ‘Gut microbiota composition and interactions with diet: dysbiosis in heart failure is partly related to lower fiber intake’ will be presented during the session Young Investigator Award – Basic Science and Translational Science on Sunday 26 May at 14:15 to 15:45 EEST in the Agora 2, Level 1.

2Mayerhofer CCK, Awoyemi AO, Moscavitch SD, et al. Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial. ESC Heart Fail. 2018;5:977–984. doi: 10.1002/ehf2.12332.

About Heart Failure and the World Congress on Acute Heart Failure

Heart Failure and the World Congress on Acute Heart Failure are annual congresses of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

About the Heart Failure Association

The Heart Failure Association (HFA) is a branch of the European Society of Cardiology (ESC). Its aim is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.


About the European Society of Cardiology

The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.

 

Information for journalists attending Heart Failure 2019

Heart Failure 2019 and the World Congress on Acute Heart Failure will be held 25 to 28 May at the Megaron Athens International Conference Centre in Athens, Greece. Explore the scientific programme.

  • To register on-site please bring a valid press card or appropriate letter of assignment with proof of three recent published articles (cardiology or health-related, or referring to a previous ESC Event).
  • Press registration is not available to industry or its public relations representatives, event management, marketing or communications representatives.